Q&A: GSK vaccine leader Judy Stewart navigates vaccination slumps, always-on marketing and innovating data tools
It’s been a tough couple of years for traditional vaccine makers. While the Covid-19 pandemic spurred a flurry of innovation and turned a white-hot spotlight on the footrace for Covid vaccine approvals, routine vaccination rates plummeted.
Early restrictions, ongoing health precautions and supply chain issues caused millions of people to skip recommended vaccines by the end of 2021. The World Health Organization recently reported that 2021 suffered “the largest sustained decline in childhood vaccinations” in 30 years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.